Ampio Pharmaceuticals Inc.
AMPE
AMPE was delisted on the 12th of April, 2024.
74 hedge funds and large institutions have $15.8M invested in Ampio Pharmaceuticals Inc. in 2016 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 11 reducing their positions, and 5 closing their positions.
360% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 11
30% more funds holding
Funds holding: 57 → 74 (+17)
23% more call options, than puts
Call options by funds: $744K | Put options by funds: $607K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less capital invested
Capital invested by funds: $19.5M → $15.8M (-$3.78M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.82M |
| 2 |
State Street
Boston,
Massachusetts
|
+$2.22M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$1.49M |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$1.2M |
| 5 |
BIM
BlackRock Investment Management
Wilmington,
Delaware
|
+$567K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$753K |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$546K |
| 3 |
TMC
Trellus Management Company
Delray Beach,
Florida
|
-$304K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$298K |
| 5 |
CP
Camelot Portfolios
Maumee,
Ohio
|
-$218K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
76
D.E. Shaw & Co
New York
| – | -$132K | -195 | Closed |
|
|
BCM
77
Bluefin Capital Management
New York
| – | -$44K | -65 | Closed |
|
|
TWA
78
TCI Wealth Advisors
Tucson,
Arizona
| – | -$3K | -5 | Closed |
|
79
Barclays
London,
United Kingdom
| – | -$1.09K | -1 | Closed |
|
|
FNYS
80
First New York Securities
New York
| – | -$108 | – | – |
|
AMPE Hedge Fund Activity: Q2 2016 in Review
74 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ampio Pharmaceuticals Inc. (AMPE) for Q2 2016, worth a combined $15.8M — down 19% from $19.5M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new AMPE positions and 5 closed out — a net gain of 18 holders — while 22 added to existing stakes and 11 trimmed.
The largest buyer was BlackRock Fund Advisors, adding an estimated $3.82M. The largest seller was Susquehanna International Group, cutting an estimated $753K.
- 74 institutional investors held Ampio Pharmaceuticals Inc. (AMPE) as of Q2 2016, up from 57 in Q1 2016.
- Funds reported $15.8M of Ampio Pharmaceuticals Inc. stock for Q2 2016, down 19% quarter-over-quarter.
- 23 funds opened new Ampio Pharmaceuticals Inc. positions in Q2 2016 and 5 closed out, a net change of +18 holders.
- The largest Ampio Pharmaceuticals Inc. buyer in Q2 2016 was BlackRock Fund Advisors, an estimated $3.82M added.
- The largest Ampio Pharmaceuticals Inc. seller in Q2 2016 was Susquehanna International Group, an estimated $753K sold.
Based on aggregated 13F filings for Q2 2016.